| Multiple Myeloma altered in cohorts of …ALTERED_INderived61 of 61show fewer |
|---|
| ← altered in cohorts of | IGHV2-70 437 / 961 cases (45 %) · ssm · MMRF-COMMPASS | — | — | Multiple Myeloma | 1 | Observed | gdc | graph → |
| ← altered in cohorts of | IGLV3-1 364 / 961 cases (38 %) · ssm · MMRF-COMMPASS | — | — | Multiple Myeloma | 1 | Observed | gdc | graph → |
| ← altered in cohorts of | IGHV2-70D 238 / 961 cases (25 %) · ssm · MMRF-COMMPASS | — | — | Multiple Myeloma | 1 | Observed | gdc | graph → |
| ← altered in cohorts of | KRAS 227 / 961 cases (24 %) · ssm · MMRF-COMMPASS · largest of 2 cohorts | — | — | Multiple Myeloma | 2 | Observed | gdc | graph → |
| ← altered in cohorts of | BCL7A 212 / 961 cases (22 %) · ssm · MMRF-COMMPASS | — | — | Multiple Myeloma | 1 | Observed | gdc | graph → |
| ← altered in cohorts of | IGLL5 211 / 961 cases (22 %) · ssm · MMRF-COMMPASS | — | — | Multiple Myeloma | 1 | Observed | gdc | graph → |
| ← altered in cohorts of | LTB 186 / 961 cases (19 %) · ssm · MMRF-COMMPASS | — | — | Multiple Myeloma | 1 | Observed | gdc | graph → |
| ← altered in cohorts of | NRAS 183 / 961 cases (19 %) · ssm · MMRF-COMMPASS · largest of 2 cohorts | — | — | Multiple Myeloma | 2 | Observed | gdc | graph → |
| ← altered in cohorts of | TTN 181 / 961 cases (19 %) · ssm · MMRF-COMMPASS | — | — | Multiple Myeloma | 1 | Observed | gdc | graph → |
| ← altered in cohorts of | MIR5195 143 / 961 cases (15 %) · ssm · MMRF-COMMPASS | — | — | Multiple Myeloma | 1 | Observed | gdc | graph → |
| ← altered in cohorts of | IGHV1-69D 115 / 961 cases (12 %) · ssm · MMRF-COMMPASS | — | — | Multiple Myeloma | 1 | Observed | gdc | graph → |
| ← altered in cohorts of | TENT5C 115 / 961 cases (12 %) · ssm · MMRF-COMMPASS | — | — | Multiple Myeloma | 1 | Observed | gdc | graph → |
| ← altered in cohorts of | MUC16 102 / 961 cases (11 %) · ssm · MMRF-COMMPASS | — | — | Multiple Myeloma | 1 | Observed | gdc | graph → |
| ← altered in cohorts of | BMP6 100 / 961 cases (10 %) · ssm · MMRF-COMMPASS | — | — | Multiple Myeloma | 1 | Observed | gdc | graph → |
| ← altered in cohorts of | IGKV4-1 99 / 961 cases (10 %) · ssm · MMRF-COMMPASS | — | — | Multiple Myeloma | 1 | Observed | gdc | graph → |
| ← altered in cohorts of | DIS3 97 / 961 cases (10 %) · ssm · MMRF-COMMPASS | — | — | Multiple Myeloma | 1 | Observed | gdc | graph → |
| ← altered in cohorts of | TMSB4X 97 / 961 cases (10 %) · ssm · MMRF-COMMPASS | — | — | Multiple Myeloma | 1 | Observed | gdc | graph → |
| ← altered in cohorts of | TRAF3 86 / 961 cases (8.9 %) · ssm · MMRF-COMMPASS | — | — | Multiple Myeloma | 1 | Observed | gdc | graph → |
| ← altered in cohorts of | CSMD3 84 / 961 cases (8.7 %) · ssm · MMRF-COMMPASS | — | — | Multiple Myeloma | 1 | Observed | gdc | graph → |
| ← altered in cohorts of | FAT4 84 / 961 cases (8.7 %) · ssm · MMRF-COMMPASS | — | — | Multiple Myeloma | 1 | Observed | gdc | graph → |
| ← altered in cohorts of | RYR2 81 / 961 cases (8.4 %) · ssm · MMRF-COMMPASS | — | — | Multiple Myeloma | 1 | Observed | gdc | graph → |
| ← altered in cohorts of | PCDH15 79 / 961 cases (8.2 %) · ssm · MMRF-COMMPASS | — | — | Multiple Myeloma | 1 | Observed | gdc | graph → |
| ← altered in cohorts of | FAT3 78 / 961 cases (8.1 %) · ssm · MMRF-COMMPASS | — | — | Multiple Myeloma | 1 | Observed | gdc | graph → |
| ← altered in cohorts of | PCLO 76 / 961 cases (7.9 %) · ssm · MMRF-COMMPASS | — | — | Multiple Myeloma | 1 | Observed | gdc | graph → |
| ← altered in cohorts of | NRXN1 75 / 961 cases (7.8 %) · ssm · MMRF-COMMPASS | — | — | Multiple Myeloma | 1 | Observed | gdc | graph → |
| ← altered in cohorts of | LRP1B 73 / 961 cases (7.6 %) · ssm · MMRF-COMMPASS | — | — | Multiple Myeloma | 1 | Observed | gdc | graph → |
| ← altered in cohorts of | IGLV4-60 71 / 961 cases (7.4 %) · ssm · MMRF-COMMPASS | — | — | Multiple Myeloma | 1 | Observed | gdc | graph → |
| ← altered in cohorts of | USH2A 71 / 961 cases (7.4 %) · ssm · MMRF-COMMPASS | — | — | Multiple Myeloma | 1 | Observed | gdc | graph → |
| ← altered in cohorts of | DUSP2 70 / 961 cases (7.3 %) · ssm · MMRF-COMMPASS | — | — | Multiple Myeloma | 1 | Observed | gdc | graph → |
| ← altered in cohorts of | BRAF 69 / 961 cases (7.2 %) · ssm · MMRF-COMMPASS | — | — | Multiple Myeloma | 1 | Observed | gdc | graph → |
| ← altered in cohorts of | ZFHX4 68 / 961 cases (7.1 %) · ssm · MMRF-COMMPASS | — | — | Multiple Myeloma | 1 | Observed | gdc | graph → |
| ← altered in cohorts of | CSMD1 67 / 961 cases (7.0 %) · ssm · MMRF-COMMPASS | — | — | Multiple Myeloma | 1 | Observed | gdc | graph → |
| ← altered in cohorts of | EYS 64 / 961 cases (6.7 %) · ssm · MMRF-COMMPASS | — | — | Multiple Myeloma | 1 | Observed | gdc | graph → |
| ← altered in cohorts of | IGHV1-69 64 / 961 cases (6.7 %) · ssm · MMRF-COMMPASS | — | — | Multiple Myeloma | 1 | Observed | gdc | graph → |
| ← altered in cohorts of | NTRK3 64 / 961 cases (6.7 %) · ssm · MMRF-COMMPASS | — | — | Multiple Myeloma | 1 | Observed | gdc | graph → |
| ← altered in cohorts of | OBSCN 64 / 961 cases (6.7 %) · ssm · MMRF-COMMPASS | — | — | Multiple Myeloma | 1 | Observed | gdc | graph → |
| ← altered in cohorts of | TXNDC5 64 / 961 cases (6.7 %) · ssm · MMRF-COMMPASS | — | — | Multiple Myeloma | 1 | Observed | gdc | graph → |
| ← altered in cohorts of | MYO1E 63 / 961 cases (6.6 %) · ssm · MMRF-COMMPASS | — | — | Multiple Myeloma | 1 | Observed | gdc | graph → |
| ← altered in cohorts of | RYR1 62 / 961 cases (6.5 %) · ssm · MMRF-COMMPASS | — | — | Multiple Myeloma | 1 | Observed | gdc | graph → |
| ← altered in cohorts of | DTX1 61 / 961 cases (6.3 %) · ssm · MMRF-COMMPASS | — | — | Multiple Myeloma | 1 | Observed | gdc | graph → |
| ← altered in cohorts of | IGLV3-25 61 / 961 cases (6.3 %) · ssm · MMRF-COMMPASS | — | — | Multiple Myeloma | 1 | Observed | gdc | graph → |
| ← altered in cohorts of | DNAH5 59 / 961 cases (6.1 %) · ssm · MMRF-COMMPASS | — | — | Multiple Myeloma | 1 | Observed | gdc | graph → |
| ← altered in cohorts of | IGHJ6 57 / 961 cases (5.9 %) · ssm · MMRF-COMMPASS | — | — | Multiple Myeloma | 1 | Observed | gdc | graph → |
| ← altered in cohorts of | DST 56 / 961 cases (5.8 %) · ssm · MMRF-COMMPASS | — | — | Multiple Myeloma | 1 | Observed | gdc | graph → |
| ← altered in cohorts of | NCAM2 56 / 961 cases (5.8 %) · ssm · MMRF-COMMPASS | — | — | Multiple Myeloma | 1 | Observed | gdc | graph → |
| ← altered in cohorts of | MMP16 55 / 961 cases (5.7 %) · ssm · MMRF-COMMPASS | — | — | Multiple Myeloma | 1 | Observed | gdc | graph → |
| ← altered in cohorts of | FAT1 54 / 961 cases (5.6 %) · ssm · MMRF-COMMPASS | — | — | Multiple Myeloma | 1 | Observed | gdc | graph → |
| ← altered in cohorts of | HMCN1 54 / 961 cases (5.6 %) · ssm · MMRF-COMMPASS | — | — | Multiple Myeloma | 1 | Observed | gdc | graph → |
| ← altered in cohorts of | CACNA1E 52 / 961 cases (5.4 %) · ssm · MMRF-COMMPASS | — | — | Multiple Myeloma | 1 | Observed | gdc | graph → |
| ← altered in cohorts of | KALRN 52 / 961 cases (5.4 %) · ssm · MMRF-COMMPASS | — | — | Multiple Myeloma | 1 | Observed | gdc | graph → |
| ← altered in cohorts of | PCDH11X 52 / 961 cases (5.4 %) · ssm · MMRF-COMMPASS | — | — | Multiple Myeloma | 1 | Observed | gdc | graph → |
| ← altered in cohorts of | CACNA2D1 51 / 961 cases (5.3 %) · ssm · MMRF-COMMPASS | — | — | Multiple Myeloma | 1 | Observed | gdc | graph → |
| ← altered in cohorts of | EGR1 51 / 961 cases (5.3 %) · ssm · MMRF-COMMPASS | — | — | Multiple Myeloma | 1 | Observed | gdc | graph → |
| ← altered in cohorts of | FSIP2 51 / 961 cases (5.3 %) · ssm · MMRF-COMMPASS | — | — | Multiple Myeloma | 1 | Observed | gdc | graph → |
| ← altered in cohorts of | NLGN1 51 / 961 cases (5.3 %) · ssm · MMRF-COMMPASS | — | — | Multiple Myeloma | 1 | Observed | gdc | graph → |
| ← altered in cohorts of | SYNE1 51 / 961 cases (5.3 %) · ssm · MMRF-COMMPASS | — | — | Multiple Myeloma | 1 | Observed | gdc | graph → |
| ← altered in cohorts of | ZNF462 51 / 961 cases (5.3 %) · ssm · MMRF-COMMPASS | — | — | Multiple Myeloma | 1 | Observed | gdc | graph → |
| ← altered in cohorts of | MYO10 50 / 961 cases (5.2 %) · ssm · MMRF-COMMPASS | — | — | Multiple Myeloma | 1 | Observed | gdc | graph → |
| ← altered in cohorts of | ROBO2 50 / 961 cases (5.2 %) · ssm · MMRF-COMMPASS | — | — | Multiple Myeloma | 1 | Observed | gdc | graph → |
| ← altered in cohorts of | SOX11 49 / 961 cases (5.1 %) · ssm · MMRF-COMMPASS | — | — | Multiple Myeloma | 1 | Observed | gdc | graph → |
| ← altered in cohorts of | VGLL3 49 / 961 cases (5.1 %) · ssm · MMRF-COMMPASS | — | — | Multiple Myeloma | 1 | Observed | gdc | graph → |